General Information of This Drug (ID: DM6D1G6)

Drug Name
BI-54903   DM6D1G6
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 2 [1]

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Olodaterol + BI-54903 DC332FF Olodaterol Asthma [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01397201) Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01428622) Olodaterol Bridging Study in Asthma. U.S. National Institutes of Health.